Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Study protocol

Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa

Authors: Supa Pengpid, Karl Peltzer, Linda Skaal

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

In persons 15 years and above in South Africa the prevalence of pre-diabetes and diabetes has been estimated at 9.1% and 9.6%, respectively, and the prevalence of systolic prehypertension and hypertension, 38.2% and 24.6%, respectively. Elevated blood glucose and elevated blood pressure are prototype of preventable chronic cardiovascular disease risk factors.
Lifestyle interventions have been shown to control high normal blood pressure and/or high normal blood glucose.

Methods/Design

This study proposes to evaluate the efficacy of a community (church)-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members in a randomized controlled trial in Gauteng, South Africa. The objectives are to: (1) measure non-communicable diseases profile, including hypertension and diabetes, health behaviours, weight management and psychological distress of church members; (2) measure the reduction of blood glucose and blood pressure levels after the intervention; (3) prevent the development of impaired glucose tolerance; (4) compare health behaviours, weight management and psychological distress, blood glucose and blood pressure levels between intervention and control groups, and within group during 6, 12, 24 and 36 months during and post intervention. The study will use a group-randomized design, recruiting 300 church members from 12 churches. Churches will be randomly assigned to experimental and control conditions.

Discussion

Lifestyle interventions may prevent from the development of high blood pressure and/or diabetes. The findings will impact public health and will enable the health ministry to formulate policy related to lifestyle interventions to control blood pressure and glucose.

Trial registration number

PACTR20110500029​7151
Appendix
Available only for authorised users
Literature
1.
Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A, Reddy P, Parker W, Hoosain E, Naidoo P, Hongoro C, Mchiza Z, Steyn NP, Dwane N, Makoae M, Maluleke T, Ramlagan S, Zungu N, Evans MG, Jacobs L, Faber M, Jooste J, Peltzer K, SANHANES-1 Team: South African National Health and Nutrition Examination Survey (SANHANES-1). 2013, Cape Town: HSRC Press
2.
Nathan DM, Meigs J, Singer DE: The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it?. Lancet. 1997, 350 (Suppl 1): SI4-SI9.CrossRefPubMed
3.
Dagogo-Jack S, Egbuonu N, Edeoga C: Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Med Princ Pract. 2010, 19 (3): 167-175. 10.1159/000285280.CrossRefPubMedPubMedCentral
4.
5.
Thomas GN, Jiang CQ, Taheri S, Xiao ZH, Tomlinson B, Cheung BM, Lam TH, Barnett AH, Cheng KK: A systematic review of lifestyle modification and glucose intolerance in the prevention of type 2 diabetes. Curr Diabetes Rev. 2010, 6 (6): 378-387. 10.2174/157339910793499092.CrossRefPubMed
6.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346: 393-403.CrossRefPubMed
7.
Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, for the Finnish Diabetes Prevention Study (DPS): Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013, 56 (2): 284-293. 10.1007/s00125-012-2752-5.CrossRefPubMed
8.
Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roquéi Figuls M, Richter B, Mauricio D: Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008, Art. No.: CD003054. doi: 10.1002/14651858.CD003054.pub3, 3CrossRef
9.
Hedayati SS, Elsayed EF, Reilly RF: Non-pharmacological aspects of blood pressure management: what are the data?. Kidney Int. 2011, 79 (10): 1061-1070. 10.1038/ki.2011.46.CrossRefPubMedPubMedCentral
10.
Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, Lin PH, Champagne CM, King AC, McGuire HL, Stevens VJ, Brantley PJ, Harsha DW, McBurnie MA, Appel LJ, Svetkey LP: Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension. 2007, 50 (4): 609-616. 10.1161/HYPERTENSIONAHA.107.089458.CrossRefPubMed
11.
Maruthur NM, Wang NY, Appel LJ: Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial. Circulation. 2009, 119 (15): 2026-2031. 10.1161/CIRCULATIONAHA.108.809491.CrossRefPubMedPubMedCentral
12.
Márquez-Celedonio FG, Téxon-Fernández O, Chávez-Negrete A, Hernández-López S, Marín-Rendón S, Berlín-Lascurain S: Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study. Rev Esp Cardiol. 2009, 62 (1): 86-90. 10.1016/S0300-8932(09)70025-9.CrossRefPubMed
13.
Papadopoulos DP, Makris TK, Papademetriou V: Is it time to treat prehypertension?. Hypertens Res. 2008, 31 (9): 1681-1686. 10.1291/hypres.31.1681.CrossRefPubMed
14.
Egan BM, Lackland DT, Jones DW: Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010, 28 (4): 561-569. 10.1016/j.ccl.2010.07.008.CrossRefPubMed
15.
Glasgow RE, Lichtenstein E, Marcus AC: Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003, 93 (8): 1261-1267. 10.2105/AJPH.93.8.1261.CrossRefPubMedPubMedCentral
16.
Lancaster KJ, Schoenthaler AM, Midberry SA, Watts SO, Nulty MR, Cole HV, Ige E, Chaplin W, Ogedegbe G: Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members. Am Heart J. 2014, 167 (3): 301-307. 10.1016/j.ahj.2013.10.026.CrossRefPubMed
17.
Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG: Translating the diabetes prevention program into the community. the DEPLOY pilot study. Am J Prev Med. 2008, 35 (4): 357-363. 10.1016/j.amepre.2008.06.035.CrossRefPubMedPubMedCentral
18.
Boltri JM, Davis-Smith M, Okosun IS, Seale JP, Foster B: Translation of the national institutes of health diabetes prevention program in African American churches. J Natl Med Assoc. 2011, 103 (3): 194-202.CrossRefPubMed
19.
Simmons D, Fleming C, Voyle J, Fou F, Feo S, Gatland B: A pilot urban church-based programme to reduce risk factors for diabetes among Western Samoans in New Zealand. Diabet Med. 1998, 15 (2): 136-142. 10.1002/(SICI)1096-9136(199802)15:2<136::AID-DIA530>3.0.CO;2-P.CrossRefPubMed
20.
Simmons D, Voyle JA, Fou F, Feo S, Leakehe L: Tale of two churches: differential impact of a church-based diabetes control programme among Pacific Islands people in New Zealand. Diabet Med. 2004, 21 (2): 122-128. 10.1111/j.1464-5491.2004.01020.x.CrossRefPubMed
21.
Oexmann MJ, Thomas JC, Taylor KB, O'Neil PM, Garvey WT, Lackland DT, Egan BM: Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000, 10 (1): 17-23.PubMed
22.
Peltzer K: Faith healing for mental and social disorders in the Northern Province (South Africa). J Rel Afr. 1999, 29: 387-402. 10.1163/157006699X00395.CrossRef
23.
Anderson A: Zion and Pentecost: the spirituality and experience of Pentecostal and Zionist/Apostolic churches in South Africa. 2000, Pretoria: Unisa Press, 6
24.
Anderson A: Pentecostal approaches to faith and healing. Intern Rev Mission. 2002, 91 (363): 523-534. 10.1111/j.1758-6631.2002.tb00365.x.CrossRef
25.
Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010, 7 (3): e1000251-10.1371/journal.pmed.1000251.CrossRefPubMedPubMedCentral
26.
Campbell MK, Elbourne DR, Altman DG: CONSORT statement: extension to cluster randomised trials. BMJ. 2004, 328 (7441): 702-708. 10.1136/bmj.328.7441.702.CrossRefPubMedPubMedCentral
27.
Anderson A: Bazalwane: African Pentecostals in South Africa. 1992, Pretoria: PhD Thesis, University of South Africa
28.
29.
Seedat YK, Rayner BL: Southern African Hypertension Society. South African hypertension guideline 2011. S Afr Med J. 2011, 102 (1 Pt 2): 57-83.PubMed
30.
Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, for the Finnish Diabetes Prevention Study (DPS): Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2012, Oct 24. doi:10.1007/s00125-012-2752-5
31.
Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, Katsilambros N: Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. Diabetes Metab. 2011, 37 (2): 144-151. 10.1016/j.diabet.2010.09.006.CrossRefPubMed
32.
Brown N, Critchley J, Bogowicz P, Mayige M, Unwin N: Risk scores based on self-reported or available clinical data to detect undiagnosed type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 2012, 98 (3): 369-385. 10.1016/j.diabres.2012.09.005.CrossRefPubMed
33.
34.
Uutela A, Absetz P, Valve R, Talja M, Fogelholm M, Nissinen A: Health psychological theory in promoting population health in Päijät-Häme, Finland: first steps toward a type 2 diabetes prevention study. J Health Psychol. 2004, 9 (1): 73-84. 10.1177/1359105304036103.CrossRefPubMed
35.
Funk KL, Elmer PJ, Stevens VJ, Harsha DW, Craddick SR, Lin PH, Young DR, Champagne CM, Brantley PJ, McCarron PB, Simons-Morton DG, Appel LJ: PREMIER-a trial of lifestyle interventions for blood pressure control: intervention design and rationale. Health Promot Pract. 2008, 9 (3): 271-280.CrossRefPubMed
36.
37.
Lambert EV, Bohlmann I, Kolbe-Alexander T: ‘Be active’- physical activity for health in South Africa. SAJCN. 2001, 14 (3): S12-S16.
38.
Schwarzer R, Fuchs R: Changing risk behaviors and adopting health behaviors: The role of self-efficacy beliefs. Self-efficacy in changing societies. Edited by: Bandura A. 1995, New York: Cambridge University Press, 259-288.CrossRef
39.
Oettingen G, Hönig G, Gollwitzer PM: Effective self-regulation of goal attainment. Intern J Educ Res. 2000, 33: 705-732. 10.1016/S0883-0355(00)00046-X.CrossRef
40.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344 (18): 1343-1350. 10.1056/NEJM200105033441801.CrossRefPubMed
41.
Petrella RJ, Aizawa K, Shoemaker K, Overend T, Piche L, Marin M, Shapiro S, Atkin S: Efficacy of a family practice-based lifestyle intervention program to increase physical activity and reduce clinical and physiological markers of vascular health in patients with high normal blood pressure and/or high normal blood glucose (SNAC): study protocol for a randomized controlled trial. Trials. 2011, 12: 45-10.1186/1745-6215-12-45.CrossRefPubMedPubMedCentral
42.
Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ: Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004, 57 (8): 785-794. 10.1016/j.jclinepi.2003.12.013.CrossRefPubMed
Metadata
Title
Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa
Authors
Supa Pengpid
Karl Peltzer
Linda Skaal
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-568

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue

Research article

Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine

Study protocol

Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)

Research article

Snacking patterns, diet quality, and cardiovascular risk factors in adults

Research article

Medical planning for mass-participation running events: a 3-year review of a half-marathon in Singapore

Research article

Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities

Research article

Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?